PLRX earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -0.60. Updated 2026-07-23.
Pliant Therapeutics (PLRX) Research Hub
Pliant Therapeutics (PLRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.8498 USD (-1.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.60, market cap 0.07B. This hub links to the full technical, earnings and options research available for PLRX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.8498 USD (-1.60%) |
| 52-week range | 0.831 USD – 1.2 USD |
| Trend regime | Range |
| 14-day RSI | 29.7 (Oversold) |
| Trailing P/E | -0.60 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for PLRX
Covered Call on PLRX: how it works, illustrative setup around the real 0.8498 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PLRX: how it works, illustrative setup around the real 0.8498 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PLRX: how it works, illustrative setup around the real 0.8498 USD price, max profit/loss, breakeven and when to use it. Educational.
PLRX technical analysis: range, last 0.8498 USD, RSI 29.7, 52w range 0.831 USD–1.2 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PLRX in?
Pliant Therapeutics (PLRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PLRX in an uptrend or downtrend?
As of 2026-10-26, PLRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PLRX's trailing P/E ratio?
PLRX's trailing P/E is -0.60, with a market cap of 0.07B. See the earnings research page for full valuation detail.
When does PLRX next report earnings?
PLRX is next scheduled to report earnings on 2026-08-06.